Co-creation of the Global Patient Experience Data Navigator: a multi-stakeholder initiative to ensure the patient voice is represented in health decision-making
Authors:
- Tom WillgossTWTom Willgoss
- Omar A. EscontriasOEOmar A. Escontrias
- Carole ScraftonCSCarole Scrafton
- Elisabeth OehrleinEOElisabeth Oehrlein
- Victoria LivingstoneVLVictoria Livingstone
- Fiona C. ChaplinFCFiona C. Chaplin
- Maddalena BeniventoMBMaddalena Benivento
- Hayley ChapmanHCHayley Chapman
- Nicholas BrookeNBNicholas Brooke
Open Access
- 12 October 2023
- journal article
- research article
- Published by Springer Nature in Research Involvement and Engagement
- Vol. 9 (1) , 1-11
Abstract
Background: Putting patients’ needs and priorities at the forefront of healthcare initiatives and medical product development is critical to achieve outcomes that matter most to patients. This relies on the integration of early, meaningful patient engagement (PE) to learn what is important to patients, and collection of representative patient experience data (PXD). The increased number of PE/PXD efforts across global regulatory, health technology assessment, and healthcare systems is an important step forward to deliver improved health outcomes for patients. However, these initiatives are fragmented and lack integration, which is necessary to maximize efforts and reduce burden on patients. To overcome these challenges, the Global Patient Experience Data Navigator has been co-created by Patient Focused Medicines Development to provide practical resources that can facilitate and optimize PXD generation, collection, analysis, and dissemination for patient benefit and aims to be applicable across all therapeutic areas for all stakeholders. Methods: Co-creation of the Navigator took place through an iterative process of validation and formalization driven by a diverse, multi-stakeholder working group with individuals who have varying knowledge/experience in PE/PXD. Results: A series of workshops took place to conduct a gap analysis, develop a taxonomy model, and integrate existing frameworks. The collective insights led to the development of the Navigator consisting of four specific tools in the form of downloadable templates, which can be used to: (1) prioritize outcomes that matter most to patients and their caregivers; (2) select appropriate measurement methods for these outcomes; (3) identify when and why PXD is used throughout the product development cycle for each stakeholder; (4) identify when and why PXD is used throughout the healthcare process for each stakeholder. A public consultation was carried out to collect user feedback before the Navigator was made publicly available in December 2022. Conclusion: To our knowledge, the Global Patient Experience Data Navigator is the only publicly available toolkit developed with a multi-stakeholder and disease-agnostic approach providing taxonomically grouped resources to optimize the collection and collation of PXD for patient benefit. Future work will aim to further engage patients by adding a PE dimension to the Navigator.Keywords
All Related Versions
Funding Information
- Patient Focused Medicines Development
This publication has 12 references indexed in Scilit:
- Patient-Centered Core Impact Sets: What They are and Why We Need ThemThe Patient - Patient-Centered Outcomes Research, 2022
- Improving Access and Quality of Health Care in the United States: Shared Goals Among Patient AdvocatesThe Patient - Patient-Centered Outcomes Research, 2020
- Amplifying the Voice of the Patient in Clinical Research: Development of Toolkits for Use in Designing and Conducting Patient-Centered Clinical StudiesTherapeutic Innovation & Regulatory Science, 2020
- FDA Reported Use of Patient Experience Data in 2018 Drug ApprovalsTherapeutic Innovation & Regulatory Science, 2020
- Using patient experience data to develop a patient experience toolkit to improve hospital care: a mixed-methods studyHealth Services and Delivery Research, 2019
- Co-creation of patient engagement quality guidance for medicines development: an international multistakeholder initiativeBMJ Innovations, 2019
- A taxonomy has been developed for outcomes in medical research to help improve knowledge discoveryJournal of Clinical Epidemiology, 2018
- Improving Patient Involvement in Medicines Research and Development: A Practical RoadmapTherapeutic Innovation & Regulatory Science, 2017
- Culture and Process Change as a Priority for Patient Engagement in Medicines DevelopmentTherapeutic Innovation & Regulatory Science, 2017
- Patient-Focused Drug DevelopmentMedical Care, 2015